Match each clinical scenario involving a newly discovered intra-abdominal lesion to the single most appropriate next step in diagnostic imaging or workup. Consider patient-specific risk factors and evidence-based society guidelines.
- An asymptomatic 58-year-old patient with an incidentally discovered 1.5 cm simple, anechoic hepatic cyst demonstrating posterior acoustic enhancement on ultrasound.No further diagnostic imaging indicated
- A 62-year-old patient with compensated cirrhosis who is found to have a new 1.4 cm solid hepatic nodule on a routine 6-month surveillance ultrasound.Quadriphasic computed tomography (CT) or multiphasic magnetic resonance imaging (MRI) of the abdomen
- A healthy 32-year-old woman with a 4 cm well-circumscribed, solitary liver lesion demonstrating a central stellate scar identified incidentally on an unenhanced CT scan.Magnetic resonance imaging (MRI) of the abdomen with hepatobiliary-specific contrast agent
- A 50-year-old patient with an incidental 3.5 cm cystic lesion in the pancreatic head containing multiple septations and a 6 mm enhancing mural nodule on an initial CT scan.Endoscopic ultrasound (EUS) with fine-needle aspiration
Cevap
The simple hepatic cyst requires no further imaging. The solid nodule in a cirrhotic patient requires quadriphasic CT or multiphasic MRI. The suspected focal nodular hyperplasia (central scar) requires an MRI with hepatobiliary-specific contrast. The pancreatic cyst with high-risk features requires endoscopic ultrasound with fine-needle aspiration.
Correct imaging workup of abdominal lesions relies on matching the modality's specific diagnostic capability to the lesion's risk profile. Multiphasic CT/MRI captures dynamic vascular patterns necessary for HCC diagnosis in cirrhosis. MRI with hepatocyte-specific contrast exploits the cellular composition of FNH for definitive diagnosis. EUS-FNA directly samples high-risk pancreatic cysts. Simple cysts require no workup.
Adım Adım Çözüm
Anahtar Kavram
Evidence-based test sequencing and imaging modality selection for incidentally discovered hepatopancreatobiliary lesions.